Extranodal localization of non-Hodgkin's lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature.

IF 1.4 Q3 RHEUMATOLOGY
Giorgio Galoppini, Beatrice Maranini, Giovanni Ciancio, Melissa Padovan, Gian Luca Casoni, Francesco Cavazzini, Roberta Gafà, Giovanni Lanza, Marcello Govoni
{"title":"Extranodal localization of non-Hodgkin's lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature.","authors":"Giorgio Galoppini,&nbsp;Beatrice Maranini,&nbsp;Giovanni Ciancio,&nbsp;Melissa Padovan,&nbsp;Gian Luca Casoni,&nbsp;Francesco Cavazzini,&nbsp;Roberta Gafà,&nbsp;Giovanni Lanza,&nbsp;Marcello Govoni","doi":"10.1177/23971983221088459","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Systemic sclerosis is associated with an increased incidence of malignancies, in particular solid neoplasms. Hematological cancers have been also observed in autoimmune diseases, though rarely present with lung involvement. The latter may be misdiagnosed in systemic sclerosis patients, due to the frequent concomitant interstitial lung disease.</p><p><strong>Case description: </strong>Here, we present the case of a 63-year-old man affected by systemic sclerosis presenting with an atypical lung imaging and splenomegaly, who was diagnosed with splenic marginal zone lymphoma, thus raising the suspicion of lung secondarism. We discuss the diagnostic challenge of differential diagnosis in interstitial lung presentation and briefly review the available literature on this topic.</p><p><strong>Conclusion: </strong>Several reports have demonstrated an increased risk of malignancy in patients with systemic sclerosis. Still, the lack of concretely defined guidelines for systemic sclerosis, along with systemic sclerosis multifaceted organ involvement at presentation, may challenge diagnosis and management. Here, we remark the importance of clinical work-up and a multidisciplinary approach in systemic sclerosis, to early detect and treat concomitant hematological malignancies, especially during the first years of the disease.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537711/pdf/10.1177_23971983221088459.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983221088459","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Systemic sclerosis is associated with an increased incidence of malignancies, in particular solid neoplasms. Hematological cancers have been also observed in autoimmune diseases, though rarely present with lung involvement. The latter may be misdiagnosed in systemic sclerosis patients, due to the frequent concomitant interstitial lung disease.

Case description: Here, we present the case of a 63-year-old man affected by systemic sclerosis presenting with an atypical lung imaging and splenomegaly, who was diagnosed with splenic marginal zone lymphoma, thus raising the suspicion of lung secondarism. We discuss the diagnostic challenge of differential diagnosis in interstitial lung presentation and briefly review the available literature on this topic.

Conclusion: Several reports have demonstrated an increased risk of malignancy in patients with systemic sclerosis. Still, the lack of concretely defined guidelines for systemic sclerosis, along with systemic sclerosis multifaceted organ involvement at presentation, may challenge diagnosis and management. Here, we remark the importance of clinical work-up and a multidisciplinary approach in systemic sclerosis, to early detect and treat concomitant hematological malignancies, especially during the first years of the disease.

系统性硬化症中非霍奇金淋巴瘤的淋巴结外定位:诊断挑战和文献综述。
背景:系统性硬化症与恶性肿瘤,特别是实体瘤的发病率增加有关。在自身免疫性疾病中也观察到了血液学癌症,尽管很少出现在肺部。后者可能在系统性硬化症患者中被误诊,因为经常伴有间质性肺病。病例描述:在此,我们报告一例63岁的系统性硬化症患者,其肺部影像学表现不典型,脾肿大,被诊断为脾脏边缘区淋巴瘤,从而增加了肺部继发性疾病的怀疑。我们讨论了间质性肺表现鉴别诊断的诊断挑战,并简要回顾了有关该主题的现有文献。结论:多份报告显示系统性硬化症患者发生恶性肿瘤的风险增加。尽管如此,缺乏针对系统性硬化症的具体定义的指南,以及系统性硬化的多方面器官参与,可能会对诊断和管理提出挑战。在这里,我们注意到系统性硬化症的临床检查和多学科方法的重要性,以早期发现和治疗伴随的血液系统恶性肿瘤,特别是在疾病的最初几年。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
31
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信